TRAINING REAXYS MEDICINAL CHEMISTRY

Similar documents
Reaxys Medicinal Chemistry Fact Sheet

DRUG DISCOVERY TODAY ELN ELN. Chemistry. Biology. Known ligands. DBs. Generate chemistry ideas. Check chemical feasibility In-house.

PIOTR GOLKIEWICZ LIFE SCIENCES SOLUTIONS CONSULTANT CENTRAL-EASTERN EUROPE

In silico pharmacology for drug discovery

In Silico Investigation of Off-Target Effects

The shortest path to chemistry data and literature

Reaxys The Highlights

Receptor Based Drug Design (1)

Introduction to Chemoinformatics and Drug Discovery

Integrated Cheminformatics to Guide Drug Discovery

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

Early Stages of Drug Discovery in the Pharmaceutical Industry

Capturing Chemistry. What you see is what you get In the world of mechanism and chemical transformations

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

FRAUNHOFER IME SCREENINGPORT

The Case for Use Cases

CSD. Unlock value from crystal structure information in the CSD

CH MEDICINAL CHEMISTRY

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.

JCICS Major Research Areas

Chemists are from Mars, Biologists from Venus. Originally published 7th November 2006

Introduction to Chemoinformatics

Principles of Drug Design

Practical QSAR and Library Design: Advanced tools for research teams

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit

Cheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS

Quantitative structure activity relationship and drug design: A Review

Evidence for the Existence of Non-monotonic Dose-response: Does it or Doesn t it?

Principles of Drug Design

ToxiCat: Hybrid Named Entity Recognition services to support curation of the Comparative Toxicogenomic Database

Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015

Overview. Database Overview Chart Databases. And now, a Few Words About Searching. How Database Content is Delivered

DiscoveryGate. One place for the answers you need. Chulalongkorn University, Thailand

Marvin 5.4 A new generation of structure indexing at Elsevier. Dr. Michael Maier, Dr. Heike Nau, Elsevier

Chemically Intelligent Experiment Data Management

The Changing Requirements for Informatics Systems During the Growth of a Collaborative Drug Discovery Service Company. Sally Rose BioFocus plc

Building innovative drug discovery alliances. Just in KNIME: Successful Process Driven Drug Discovery

ImprovIng ADmE ScrEEnIng productivity In Drug DIScovEry

Reaxys Managing Complexity

Using AutoDock for Virtual Screening

Handling Human Interpreted Analytical Data. Workflows for Pharmaceutical R&D. Presented by Peter Russell

Introducing a Bioinformatics Similarity Search Solution

ASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS

Product Guide. Thermo Scientific Cellomics HCS Solution

A powerful site for all chemists CHOICE CRC Handbook of Chemistry and Physics

Virtual screening in drug discovery

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS

Chemical Data Retrieval and Management

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

Reaxys Improved synthetic planning with Reaxys

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE

Kalexsyn Overview Kalexsyn, Inc Campus Drive Kalamazoo, MI Phone: (269) Fax: (269)

Cheminformatics platform for drug discovery application

Everyday NMR. Innovation with Integrity. Why infer when you can be sure? NMR

DiscoveryGate databases content

Advanced Medicinal Chemistry SLIDES B

Using Web Technologies for Integrative Drug Discovery

THE RELATIONSHIP BETWEEN NATURAL PRODUCTS AND SYNTHETIC. Poldhune Parc Owles, Carbis Bay, St. Ives, Cornwall TR26 2RE, UK.

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Biologically Relevant Molecular Comparisons. Mark Mackey

Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds

WALKUP LC/MS FOR PHARMACEUTICAL R&D

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.

Validation of the GastroPlus TM Software Tool and Applications

Introduction. OntoChem

Reaxys Pipeline Pilot Components Installation and User Guide

Notes of Dr. Anil Mishra at 1

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

ABI 3200 Q TRAP LC/MS/MS System

MDL Databases. Solutions At Every Stage in the R&D Process. MDL Databases. Information Systems, Inc.

ADME SCREENING OF NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES

Design Drugs Collaboratively Using Spotfire Visualization and Analysis

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Design and Synthesis of the Comprehensive Fragment Library

Structure-Based Drug Discovery An Overview

Bioorganic & Medicinal Chemistry

Course Plan for Pharmacy (Bachelor Program) No.: (2016/2017) Approved by Deans Council by decision (09/26/2016) dated (03/08/2016) )160) Credit Hours

bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012

Application integration: Providing coherent drug discovery solutions

PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS

Chemoinformatics and information management. Peter Willett, University of Sheffield, UK

Priority Setting of Endocrine Disruptors Using QSARs

Structural biology and drug design: An overview


Simulating the drug discovery pipeline: a Monte Carlo approach

COMBINATORIAL CHEMISTRY: CURRENT APPROACH

Solved and Unsolved Problems in Chemoinformatics

Navigating between patents, papers, abstracts and databases using public sources and tools

Course Specification Medicinal Chemistry-1

The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL

Data Mining in the Chemical Industry. Overview of presentation

Erfassung und Speicherung von Forschungsdaten im Fachbereich Chemie

COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS

Ákos Tarcsay CHEMAXON SOLUTIONS

Database Speaks. Ling-Kang Liu ( 劉陵崗 ) Institute of Chemistry, Academia Sinica Nangang, Taipei 115, Taiwan

Virtual Screening: How Are We Doing?

SciFinder The choice for chemistry research

Molecular Dynamics Simulations in Drug Discovery. Thomas Fox Discovery Research Boehringer Ingelheim Pharma GmbH & Co KG April 2017

Transcription:

TRAINING REAXYS MEDICINAL CHEMISTRY 1

SITUATION: DRUG DISCOVERY Knowledge survey Therapeutic target Known ligands Generate chemistry ideas Chemistry Check chemical feasibility ELN DBs In-house Analyze SAR Synthesize or buy Report Test Journals ELN Biology Check ADME/Tox No single solution will fit all needs, but Flatfiles Docs Journals 2

In-house Knowledge survey Therapeutic target Known ligands Generate chemistry ideas Chemistry Check chemical feasibility ELN Analyze SAR Synthesize or buy Report Test Wouldn t is that it be really nice necessary? being able to Check switch Hows seamlessly about interoperability ADME/Tox between scientific and domains and integration? find data that you have Biology not even thought about, but would be important? Docs 3 Flatfiles

PART OF LIFE SCIENCE SOLUTIONS A SUITE OF INTEROPERABLE, DOMAIN-SPECIFIC, DECISION SUPPORT TOOLS MEDSCAN REAXYS CHEMISTRY DISCOVERY ENGINE Combines relevant chemistry information from 16,000 periodicals TARGETINSIGHTS and over 500m experimentally validated facts with synthesis planning functionality. REAXYS MEDICINAL CHEMISTRY Identify, optimize and prioritize compounds PATHWAY with optimum STUDIO affinity, selectivity and ADMET properties. (CONTENT) INTEGRATION PHARMAPENDIUM TAXONOMIES EMBASE QUOSA 6

CONTENT COVERAGE 7

ESSENTIAL INFORMATION: 100+ EXPERIMENTAL FIELDS Reaxys Medicinal Chemistry excerpts all the relevant Quantitative data

ESSENTIAL INFORMATION: SUPPORTING CRITICAL STAGES IN THE DRUG DISCOVERY & DEVELOPMENT PIPELINE 9 COMPUTATIONAL CHEMIST (CADD*) I need to find hits for druggable targets (virtual screening) MEDICINAL CHEMIST I need to optimize chemical structures in order to improve affinity, selectivity ADMET properties and decrease side effects PHARMACOLOGIST I need to define relevant pharmacological models on animals DISCOVERY HIT TO LEAD LEAD OPTIMIZATION PRECLINICAL DEVELOPMENT COMPUTATIONAL CHEMIST (CADD*) I need to optimize affinity and selectivity of hits (Structure based design QSAR) COMPUTATIONAL CHEMIST (CADD*) I need to optimize other pharmaceutical properties while maintaining affinity (QSPR) SYNTHETIC CHEMIST I need to define the easiest and most productive way to reach my target compound PROJECT MANAGER I need to be up to date with regards to competitors working on the same subjects (Which compounds, targets are published in Journals and/or patents)

THE WORLD OF MEDICINAL CHEMISTRY AT YOUR FINGERTIPS 10 REAXYS MEDICINAL CHEMISTRY: THE MOST POWERFUL AND VERSATILE MEDICINAL CHEMISTRY DISCOVERY ENGINE ESSENTIAL INFORMATION 2.4 M chemical compounds 9 M biological experimental results 5100 Pharmacological targets RELEVANT ANSWERS Chemistry driven searches (Substructure/Similarity) Pharmacology driven searches (Target, Cell, Bioassay) Taxonomies-driven searches ACTIONABLE Intuitive and powerful user-interface No access barrier Flexible export (Manageable by user)

REAXYS MEDICINAL CHEMISTRY : PATENTS COVERAGE Patents Origin and starting date Patents count : 50632 US : 1971-present EP : 1979-present WO : 1978-present (English only) Patents are coming from the A61K class mainly but not only.

REAXYS MEDICINAL CHEMISTRY : JOURNALS COVERAGE 206421 articles are included in Reaxys Medicinal Chemistry corresponding to 1047 Journals from 1980 to present. Some articles stored in Reaxys Medicinal Chemistry are older than 1980. 1000 articles spread between 1979 and 1941.

ESSENTIAL INFORMATION COMPOUND CHEMICAL STRUCTURE,NAME, CODE, SYNONYM OF COMPOUND DRUGGABLE TARGET EXPLORE TARGET AFFINITY PATTERNS OF CHEMICAL COMPOUNDS IN VITRO AND CELL BASED ASSAYS IN VITRO ASSAYS (BINDING, SECOND MESSENGER ETC..) AND CELL BASED ASSAYS FOR EXAMPLE : AGGREGATION, ANGIOGENESIS, APOPTOSIS, CELL DIFFERENTIATION, CELLULAR CYCLE, CHONDROGENESIS ANIMAL MODELS DISEASE OVARIECTOMIZED RAT IN OSTEOPOROSIS, TREATMENT OF GLAUCOMA, XENOGRAFTED ANIMALS WITH TUMORS TO TEST AND DEVELOP ANTINEPLASTIC DRUGS PHARMACOKINETIC AND ADME PROPERTIES METABOLIC STABILITY, INTRINSIC CLEARANCE, HALF LIFE OF ELIMINATION, BIOAVAILABILITY, IN VIVO CLEARANCE TOXICITY CYTOTOXICITY, CARDIOTOXICITY, CHRONIC TOXICITY

INTERACT WITH YOUR WORKFLOW 14 Link to full text articles Link to Reaxys: Compounds Citations Link to full text Patent: Espacenet Link to Drug Bank Link to Uniprot Link to Embase Link to Protein 3D structure: PDB Export data in multiple formats: Text, Excel, SDF, RDF, XML files to be incorporated into third party tools

THANK YOU QUESTIONS? 15